{"id":690,"date":"2024-10-20T02:15:37","date_gmt":"2024-10-20T02:15:37","guid":{"rendered":"http:\/\/wmtc2006.com\/?p=690"},"modified":"2024-10-20T02:15:37","modified_gmt":"2024-10-20T02:15:37","slug":"cyan-boxes-highlight-the-cropped-portion-presented-in-supplementary-or-primary-statistics","status":"publish","type":"post","link":"https:\/\/wmtc2006.com\/?p=690","title":{"rendered":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics"},"content":{"rendered":"<p>\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics. from limma digesting of MM1s cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data9.csv (1.0M) DOI:?10.7554\/eLife.38430.014 Figure 1source data 10: Output from limma handling of SK-N-DZ cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data10.csv (1.2M) DOI:?10.7554\/eLife.38430.015 Figure 1source data 11: Output from limma digesting of SK-N-DZ cells CC-220 vs.?DMSO mass spectrometry test. elife-38430-fig1-data11.csv (1.2M) DOI:?10.7554\/eLife.38430.016 Figure 1source data 12: Output from limma digesting of SK-N-DZ cells dBET57 vs.?DMSO mass spectrometry test. elife-38430-fig1-data12.csv (1.2M) DOI:?10.7554\/eLife.38430.017 Body 1source data 13: Output from limma handling of SK-N-DZ cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data13.csv (1.0M) DOI:?10.7554\/eLife.38430.018 Figure 1source data 14: Output from limma digesting of SK-N-DZ cells pomalidomide?+MLN4924 vs.?DMSO mass spectrometry test. elife-38430-fig1-data14.csv (1.0M) DOI:?10.7554\/eLife.38430.019 Body 1source data 15: Uncropped immunoblots. Uncropped traditional <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=gene&#038;cmd=Retrieve&#038;dopt=full_report&#038;list_uids=1896\">EDA<\/a> western blots using the matching supplementary or primary body amounts shown. GAPDH launching control is offered each story. Size markers (kDa) are indicated. Cyan boxes highlight the cropped portion presented in supplementary or primary statistics. SALL4 is portrayed in two isoforms, which we observe at 150 and 100 kDa obvious molecular weights. Different cell lines may actually express different comparative degrees of these isoforms. Extra variance in obvious molecular weight might arise from post-translational modifications. elife-38430-fig1-data15.pdf (252K) DOI:?10.7554\/eLife.38430.020 Body 2source data 1: Uncropped immunoblots. (A?J) Uncropped traditional western blots using the matching supplementary or primary body amounts shown. GAPDH launching control is offered each story. Size markers (kDa) are indicated. Cyan containers high light the cropped portion presented in primary or supplementary statistics. SALL4 is portrayed in two isoforms, which we observe at 150 and 100 kDa obvious molecular weights. Different cell lines may actually express different comparative degrees of these isoforms. Extra variance in obvious molecular pounds may occur from post-translational adjustments. elife-38430-fig2-data1.pdf (3.8M) DOI:?10.7554\/eLife.38430.024 Body 3source data 1: Uncropped immunoblots. (A?B) Uncropped american blots using the corresponding supplementary or primary body amounts shown. GAPDH launching control is offered each story. Size markers (kDa) are indicated. Cyan containers high light the cropped portion presented in primary or supplementary statistics. SALL4 is portrayed in two isoforms, which we observe at 150 and 100 kDa obvious molecular weights. Methacholine chloride Different cell lines may actually express different comparative degrees of these isoforms. Extra variance in obvious molecular pounds may occur from post-translational adjustments. elife-38430-fig3-data1.pdf (466K) DOI:?10.7554\/eLife.38430.027 Body 4source data 1: Uncropped immunoblots. (A?J) Uncropped traditional western blots using the matching primary or supplementary body amounts shown. GAPDH launching control is offered each story. Size markers (kDa) are indicated. Cyan containers high light the cropped portion presented in primary or supplementary statistics. SALL4 is portrayed in two isoforms, which we observe at 150 and 100 kDa obvious molecular weights. Different cell lines may actually express different comparative degrees of these isoforms. <a href=\"https:\/\/www.adooq.com\/methacholine-chloride.html\">Methacholine chloride<\/a> Extra variance in obvious molecular pounds may occur from post-translational adjustments. elife-38430-fig4-data1.pdf (2.0M) DOI:?10.7554\/eLife.38430.030 Transparent reporting form. elife-38430-transrepform.pdf (306K) DOI:?10.7554\/eLife.38430.032 Data Availability StatementAll mass spectrometry raw data is deposited and offered via the Satisfaction archive under accessions: PXD010416, PXD010417, PXD010418, PXD010420, PDX010428. Supply files have already been provided for everyone figures. The next datasets had been generated: Donovan KAFischer Ha sido2018Thalidomide promotes degradation of SALL4, a transcription aspect implicated in Duane Radial Ray Symptoms, component 1https:\/\/www.ebi.ac.uk\/pride\/archive\/projects\/PXD010416Publicly offered by EBI Satisfaction (accession simply no: PXD010416) Donovan KAFischer ES2018Thalidomide promotes degradation of SALL4, a transcription aspect implicated in Duane Radial Ray Syndrome, part 2https:\/\/www.ebi.ac.uk\/pride\/archive\/projects\/PXD010417Publicly offered by EBI Satisfaction (accession simply no: PXD010417) Donovan KAFischer ES2018Thalidomide promotes degradation of SALL4, a transcription aspect implicated in Duane Radial Ray Syndrome, part 3https:\/\/www.ebi.ac.uk\/pride\/archive\/projects\/PXD010418Publicly offered by EBI Satisfaction (accession simply no: PXD010418) Donovan KAFischer ES2018Thalidomide promotes degradation of SALL4, a transcription aspect implicated in Duane Radial Ray Syndrome, part 5https:\/\/www.ebi.ac.uk\/pride\/archive\/projects\/PXD010420Publicly offered by EBI Satisfaction (accession simply no: PXD010420) Donovan KAFischer ES2018Thalidomide promotes degradation of SALL4, a transcription aspect implicated in Duane Radial Ray Syndrome, part 6https:\/\/www.ebi.ac.uk\/pride\/archive\/projects\/PXD010428Publicly offered by EBI Satisfaction (accession simply no: PXD010428) Abstract In historical tries to treat morning hours sickness, usage of the medication Methacholine chloride thalidomide resulted in the delivery of a large number of kids with severe delivery flaws. Despite their teratogenicity, thalidomide and related IMiD medications certainly are a mainstay of tumor treatment now; however, the molecular basis underlying the pleiotropic characteristic and biology birth flaws continues to be unknown. Here we present that IMiDs disrupt a wide transcriptional network through induced degradation of many C2H2 zinc finger Methacholine chloride transcription elements, including SALL4, a.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics. from limma digesting of MM1s cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data9.csv (1.0M) [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":["post-690","post","type-post","status-publish","format-standard","hentry","category-hedgehog-signaling"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wmtc2006.com\/?p=690\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists\" \/>\n<meta property=\"og:description\" content=\"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics. from limma digesting of MM1s cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data9.csv (1.0M) [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wmtc2006.com\/?p=690\" \/>\n<meta property=\"og:site_name\" content=\"Discovery and characterization of Histamine-2 Receptor Antagonists\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-20T02:15:37+00:00\" \/>\n<meta name=\"author\" content=\"wpadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690\"},\"author\":{\"name\":\"wpadmin\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\"},\"headline\":\"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics\",\"datePublished\":\"2024-10-20T02:15:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690\"},\"wordCount\":836,\"articleSection\":[\"Hedgehog Signaling\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690\",\"url\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690\",\"name\":\"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#website\"},\"datePublished\":\"2024-10-20T02:15:37+00:00\",\"author\":{\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/wmtc2006.com\\\/?p=690\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=690#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/wmtc2006.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#website\",\"url\":\"http:\\\/\\\/wmtc2006.com\\\/\",\"name\":\"Discovery and characterization of Histamine-2 Receptor Antagonists\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/wmtc2006.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\",\"name\":\"wpadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"caption\":\"wpadmin\"},\"sameAs\":[\"http:\\\/\\\/wmtc2006.com\"],\"url\":\"https:\\\/\\\/wmtc2006.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wmtc2006.com\/?p=690","og_locale":"en_US","og_type":"article","og_title":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists","og_description":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics. from limma digesting of MM1s cells pomalidomide vs.?DMSO mass spectrometry test. elife-38430-fig1-data9.csv (1.0M) [...]","og_url":"https:\/\/wmtc2006.com\/?p=690","og_site_name":"Discovery and characterization of Histamine-2 Receptor Antagonists","article_published_time":"2024-10-20T02:15:37+00:00","author":"wpadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wpadmin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wmtc2006.com\/?p=690#article","isPartOf":{"@id":"https:\/\/wmtc2006.com\/?p=690"},"author":{"name":"wpadmin","@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776"},"headline":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics","datePublished":"2024-10-20T02:15:37+00:00","mainEntityOfPage":{"@id":"https:\/\/wmtc2006.com\/?p=690"},"wordCount":836,"articleSection":["Hedgehog Signaling"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/wmtc2006.com\/?p=690","url":"https:\/\/wmtc2006.com\/?p=690","name":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics - Discovery and characterization of Histamine-2 Receptor Antagonists","isPartOf":{"@id":"http:\/\/wmtc2006.com\/#website"},"datePublished":"2024-10-20T02:15:37+00:00","author":{"@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776"},"breadcrumb":{"@id":"https:\/\/wmtc2006.com\/?p=690#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wmtc2006.com\/?p=690"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wmtc2006.com\/?p=690#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/wmtc2006.com\/"},{"@type":"ListItem","position":2,"name":"\ufeffCyan boxes highlight the cropped portion presented in supplementary or primary statistics"}]},{"@type":"WebSite","@id":"http:\/\/wmtc2006.com\/#website","url":"http:\/\/wmtc2006.com\/","name":"Discovery and characterization of Histamine-2 Receptor Antagonists","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/wmtc2006.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776","name":"wpadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","caption":"wpadmin"},"sameAs":["http:\/\/wmtc2006.com"],"url":"https:\/\/wmtc2006.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=690"}],"version-history":[{"count":1,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/690\/revisions"}],"predecessor-version":[{"id":691,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/690\/revisions\/691"}],"wp:attachment":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}